{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"15"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"401"},{"groupId":"OG001","value":"377"}],"units":"Participants"}],"title":"ALT or AST > 3.0*ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"401"},{"groupId":"OG001","value":"377"}],"units":"Participants"}],"title":"ALT or AST > 5.0*ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"401"},{"groupId":"OG001","value":"377"}],"units":"Participants"}],"title":"ALT or AST > 10.0*ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"401"},{"groupId":"OG001","value":"377"}],"units":"Participants"}],"title":"ALT or AST > 20.0*ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"401"},{"groupId":"OG001","value":"376"}],"units":"Participants"}],"title":"Total Bilirubin > 2.0*ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"401"},{"groupId":"OG001","value":"376"}],"units":"Participants"}],"title":"ALT or AST>3.0*ULN, tBIL>2.0 ULN, 1day"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"401"},{"groupId":"OG001","value":"376"}],"units":"Participants"}],"title":"ALT or AST>3.0*ULN, tBIL>2.0 ULN,30day"},{"categories":[{"measurements":[{"groupId":"OG000","value":"159"},{"groupId":"OG001","value":"78"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"382"},{"groupId":"OG001","value":"361"}],"units":"Participants"}],"title":"TSH > ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"60"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"382"},{"groupId":"OG001","value":"361"}],"units":"Participants"}],"title":"TSH < LLN"}],"denoms":[{"counts":[{"groupId":"OG000","value":"406"},{"groupId":"OG001","value":"397"}],"units":"Participants"}],"description":"Aspartate aminotransferase, AST. Alanine aminotransaminase, ALT. Total bilirubin, tBIL. Thyroid stimulating hormone, TSH. Upper limit of normal (ULN). Units per Liter (U/L). Results reported in International System of Units (SI).","groups":[{"description":"Nivolumab at 3 mg/kg solution provided intravenously every 2 weeks until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends.","id":"OG000","title":"Nivolumab"},{"description":"Everolimus provided in 10 mg tablets by mouth daily until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends.","id":"OG001","title":"Everolimus"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"To all treated participants with evaluable measurements","reportingStatus":"POSTED","timeFrame":"Day 1 to 30 days post study completion (approximately 106 months)","title":"Number of Participants Meeting Marked Laboratory Abnormality Criteria in Specific Liver and Thyroid Tests","type":"SECONDARY","unitOfMeasure":"Participants"}